Skip to content
Search

Latest Stories

Increase community pharmacy funding to avoid damaging closures, recommends new report

A policy brief, developed by researchers from the University of Bath and University of Strathclyde with funding from Sigma Pharmaceuticals, has recommended the Department of Health and Social Care (DHSC) and NHS to increase community pharmacy funding to avoid damaging closures and diminution of quality. 

The report launched on Wednesday (12 June) at an event in the House of Commons, attended by Members of Parliament, senior policymakers and the pharmacy industry, analysed community pharmacy policies and spoke to stakeholders to explore their opinions of the future of community pharmacy.


It was found that patients value their community pharmacies, but staff feel demotivated, insecure and undervalued. 

Stakeholders and policies suggested that in the future, medicines should be supplied by automated ‘hub and spoke’ dispensing, enabling community pharmacy staff to provide services that relieve pressure on GP surgeries, such as long-term conditions management, urgent care and public health. 

However, this will require new training, access to health records and national commissioning with sufficient funding based on the quality of services. To achieve this, the report suggested professional leadership must be stronger, more unified and proactive; professional policies should be more transparent with greater stakeholder involvement and there is also a need for some community pharmacies to provide more space and greater privacy. 

In its recommendation to DHSC and NHS, the report has suggested reform of the NHS community pharmacy contract to reward quality, not dispensing volume; facilitate ‘hub and spoke dispensing’, while ensuring that all patients can quickly access urgent medicines and have face-to-face contact with a pharmacist whenever they need it; ensure funding and provision of training for all community pharmacy staff to provide new services, especially independent prescribing;  include support to release staff to study during pharmacy opening hours; provide community pharmacists with read and write access to patient health records, with appropriate safeguards aligned to patient preferences; and align NHS contracts for GPs and community pharmacies to encourage collaboration, not competition. 

Recommendation to Pharmacy Professional 

The report has recommended the pharmacy professional to take urgent action to better support the community pharmacy workforce to feel motivated, secure and valued. 

It suggested ensuring that professional leadership and representation for community pharmacy is stronger, and more proactive than at present. Give a united message to multiple audiences such as the public, NHS and Government. 

It added: “Develop policies with greater transparency and stakeholder involvement, to ensure they focus on patient and NHS need. Ensure community pharmacy policies and culture prioritise the quality of care. Generate more evidence for the safety and effectiveness of community pharmacy services. 

Develop more community pharmacy services for mental health, cancer and health inequalities. Ensure funding and provision of training for all community pharmacy staff to provide new services, especially independent prescribing. Include support to release staff to study during pharmacy opening hours. Ensure all community pharmacies have sufficient high-quality, private space for patient services. 

Dr Matthew Jones, Senior Lecturer in the Department of Life Sciences at the University of Bath, said: “Community pharmacies already supply medicines and provide medical consultations to the public without the need for an appointment. 

“They are generally more accessible than GPs, as around 89% of people live within 20 minutes’ walk of a community pharmacy, and many have extended opening hours, including at times when GP surgeries are normally closed.

“It makes sense to empower pharmacists to increase their patient-facing work to safely and effectively manage long-term conditions such as diabetes or asthma, minor ailments such as sore throats and earache, and promote public health with vaccinations and smoking cessation services.

“However, putting this in place requires new training, full access to health records and national commissioning with sufficient funding based on the quality of services. We believe making more effective use of community pharmacists could go a long way to help address the current NHS challenges in GP services.”

Dr Piotr Ozieranski, Reader in the Department of Social Policy Sciences at the University of Bath, said: “Our research highlights a key role community pharmacists could play in the face of increased pressure on GP services. 

“This requires a rethink and overhaul of how prescriptions are currently managed, but we see an opportunity here which the Government should seize."

Professor Margaret Watson, Professor of Health Services Research and Pharmacy Practice at the University of Strathclyde said: "Community pharmacy personnel achieved so much throughout the Covid pandemic; imagine what could be achieved with appropriate funding and workforce enablement.

“Pharmacists are society's experts on medicines, which are the most commonly used healthcare treatment. 

“Government investment in community pharmacy services isn't just good for health it's essential for building a better future for the people of Britain."

The findings of this project, funded by Sigma Pharmaceuticals, have also been supplied as evidence to the current Health & Social Care Committee Pharmacy Inquiry. 

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less